Robotic Gait denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for robotic gait are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Robotic Gait
## Why BCBS Denied Robotic Gait Training Under Step Therapy — and Why You Can Appeal
Blue Cross Blue Shield plans use step-therapy protocols to require that patients try less intensive or lower-cost rehabilitation options before authorizing robotic-assisted gait training. A typical step-therapy denial means BCBS has determined the patient has not yet completed a required trial of conventional physical therapy, treadmill training, or other gait rehabilitation before advancing to robotic-assisted devices. However, step-therapy denials are frequently overturned when the patient has already completed the required prior steps, when those steps are contraindicated by the patient's clinical condition, or when the patient's diagnosis category makes skipping to robotic training clinically appropriate under published guidelines.
## Your Appeal Rights
Many states have enacted step-therapy reform laws that require insurers to grant step-therapy exceptions when the required first-line treatment is contraindicated, was already tried and failed, or would cause clinically significant harm. Even in states without specific step-therapy statutes, ACA Section 2719 guarantees independent external review for non-grandfathered plans, and ERISA Section 503 requires a full-and-fair internal review with written justification for any denial. An expedited appeal is available if waiting for step-therapy completion would jeopardize your health or functional recovery. The external review window generally extends roughly four months from exhaustion of internal remedies.
## The Appeal Process and Timeline
1. Identify the required steps: the denial letter must specify which prior therapy steps BCBS considers unmet. If it does not, request this information in writing. 2. File a first-level internal appeal, demonstrating either that prior steps were completed (with records) or that a clinical exception applies. 3. If denied internally, escalate to external review and explicitly invoke any applicable state step-therapy exception law in your appeal. 4. In parallel, ask the treating provider whether a peer-to-peer review with BCBS's medical director is available — clinician-to-clinician conversations often resolve step-therapy disputes faster than formal appeals.
## Documentation to Gather
- Prior therapy records: all records showing conventional physical therapy, treadmill gait training, and any other step-therapy requirement — with dates, session counts, and documented outcomes — to prove the required steps were already completed.
- Failure or contraindication documentation: if required steps were not completed because they were contraindicated or clinically inappropriate, a letter from the treating physician explaining this with reference to the patient's specific diagnosis and functional limitations.
- Functional severity assessment: objective gait and balance assessments from the chart demonstrating that the patient's impairment severity supports advancing directly to robotic-assisted training.
- Prescriber medical-necessity letter: explaining why the clinical picture — diagnosis, severity, prior treatment response — supports robotic gait training as the appropriate next step.
- Applicable guideline reference: cite the relevant rehabilitation medicine or neurology society's guidance (generically) that supports robotic gait training for patients with this diagnosis category who meet specified functional criteria.
## Criteria-Mapping Structure
Obtain BCBS's published step-therapy protocol or coverage policy for robotic rehabilitation. For each required step, create a two-column table: the protocol requirement and the specific record confirming it was met (or the clinical reason it was appropriately bypassed). If the patient completed all required steps, the appeal is straightforward. If steps were bypassed for clinical reasons, build a clear argument under the applicable step-therapy exception framework — particularly the "clinically contraindicated" or "prior failure" exception grounds.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus